MARATTO

article · Clinical Medicine Insights Pediatrics

Assessment of Serum Interleukins 18 and 22 in Predicting Neonatal Sepsis and Mortality: A Case-Control Study

2026Open accessSohag University

In plain language

The abstract on record is too brief for a reliable plain-language summary, so none has been generated.

Abstract

IL-18 and IL-22 are potentially promising biomarkers for identifying NS and predicting neonatal mortality.

Research topics

  • Neonatal and Maternal Infections
  • Preterm Birth and Chorioamnionitis
  • Inflammasome and immune disorders

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1177/11795565251403180

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.